Leerink Swann Upgrades Luminex (LMNX) to Outperform Following EraGen Acquisition
Get Alerts LMNX Hot Sheet
Price: $36.99 --0%
Rating Summary:
1 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Rating Summary:
1 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 9
Join SI Premium – FREE
Leerink Swann upgraded Luminex (NASDAQ: LMNX) from Market Perform
to Outperform. Valuation increased to $23-$25 (from $20-$22)
Leerink analyst says, "We view LMNX's announced acquisition of EraGen Biosciences favorably and believe EraGen not only expands LMNX's revenue base but also its opportunity set. The deal offers an opportunity for meaningful value creation if managed properly, and we believe investors will come to increasingly appreciate this value over time."
For more ratings news on Luminex click here and for the rating history of Luminex click here.
Shares of Luminex closed at $19.64 yesterday.
to Outperform. Valuation increased to $23-$25 (from $20-$22)
Leerink analyst says, "We view LMNX's announced acquisition of EraGen Biosciences favorably and believe EraGen not only expands LMNX's revenue base but also its opportunity set. The deal offers an opportunity for meaningful value creation if managed properly, and we believe investors will come to increasingly appreciate this value over time."
For more ratings news on Luminex click here and for the rating history of Luminex click here.
Shares of Luminex closed at $19.64 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Keefe, Bruyette & Woods Upgrades Trustmark (TRMK) to Outperform
- Needham Upgrades Silicon Labs (SLAB) to Buy
- JPMorgan Upgrades Unilever Indonesia Tbk (UNVR:IJ) (UNLRF) to Neutral
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!